HDAC9 and familial pancreatic carcinoma: IL-13Rα2-negative pancreatic cancer cell lines (Panc-1 and ASPC-1) were implanted in the flanks of immunodeficient mice and treated with two different HDAC inhibitors, TSA and SAHA followed by IL-13-PE immunotoxin.